Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Axogen Inc (AXGN)

Axogen Inc (AXGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,591,670
  • Shares Outstanding, K 46,122
  • Annual Sales, $ 187,340 K
  • Annual Income, $ -9,960 K
  • EBIT $ 4 M
  • EBITDA $ 13 M
  • 60-Month Beta 1.00
  • Price/Sales 7.39
  • Price/Cash Flow N/A
  • Price/Book 12.95

Options Overview Details

View History
  • Implied Volatility 75.45% (-2.58%)
  • Historical Volatility 44.28%
  • IV Percentile 44%
  • IV Rank 28.84%
  • IV High 134.13% on 11/21/25
  • IV Low 51.67% on 12/23/25
  • Expected Move (DTE 9) 1.70 (5.01%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 8
  • Volume Avg (30-Day) 83
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 1,937
  • Open Int (30-Day) 1,790
  • Expected Range 32.20 to 35.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.01
  • Number of Estimates 3
  • High Estimate 0.00
  • Low Estimate -0.02
  • Prior Year 0.01
  • Growth Rate Est. (year over year) -200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.95 +13.19%
on 01/14/26
36.00 -5.83%
on 02/02/26
+0.39 (+1.16%)
since 01/09/26
3-Month
23.00 +47.39%
on 11/18/25
36.00 -5.83%
on 02/02/26
+9.44 (+38.59%)
since 11/11/25
52-Week
9.22 +267.88%
on 06/18/25
36.00 -5.83%
on 02/02/26
+16.38 (+93.49%)
since 02/11/25

Most Recent Stories

More News
Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

ALACHUA, Fla. and TAMPA, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 33.90 (-1.77%)
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 33.90 (-1.77%)
Axogen Announces Proposed Public Offering of Common Stock

ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 33.90 (-1.77%)
Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025

ALACHUA, Fla. and TAMPA, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 33.90 (-1.77%)
Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference

ALACHUA, Fla. and TAMPA, Fla., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 33.90 (-1.77%)
Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)

ALACHUA, Fla. and TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical technologies for the restoration of peripheral...

AXGN : 33.90 (-1.77%)
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

ALACHUA, Fla. and TAMPA, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 33.90 (-1.77%)
AxoGen: Q3 Earnings Snapshot

AxoGen: Q3 Earnings Snapshot

AXGN : 33.90 (-1.77%)
Axogen, Inc. Reports Third Quarter 2025 Financial Results

ALACHUA, Fla. and TAMPA, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 33.90 (-1.77%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN

NEW YORK , Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Axogen, Inc. ("Axogen" or the "Company") (NASDAQ: AXGN). Such investors are advised to contact...

AXGN : 33.90 (-1.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch...

See More

Key Turning Points

3rd Resistance Point 39.19
2nd Resistance Point 36.97
1st Resistance Point 35.43
Last Price 33.90
1st Support Level 31.67
2nd Support Level 29.45
3rd Support Level 27.91

See More

52-Week High 36.00
Last Price 33.90
Fibonacci 61.8% 25.77
Fibonacci 50% 22.61
Fibonacci 38.2% 19.45
52-Week Low 9.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar